Considering whether Medicaid is worth the cost

Revisiting the Oregon Health Study

Peter A. Muennig, Ryan Quan, Codruta Chiuzan, Sharon Glied

Research output: Contribution to journalReview article

Abstract

The Oregon Health Study was a groundbreaking experiment in which uninsured participants were randomized to either apply for Medicaid or stay with their current care. The study showed that Medicaid produced numerous important socioeconomic and health benefits but had no statistically significant impact on hypertension, hypercholesterolemia, or diabetes. Medicaid opponents interpreted the findings to mean that Medicaid is not a worthwhile investment. Medicaid proponents viewed the experiment as statistically underpowered and, irrespective of the laboratory values, suggestive that Medicaid is a good investment. We tested these competing claims and, using a sensitive joint test and statistical power analysis, confirmed that the Oregon Health Study did not improve laboratory values. However, we also found that Medicaid is a good value, with a cost of just $62 000 per quality-adjusted life-years gained.

Original languageEnglish (US)
Pages (from-to)866-871
Number of pages6
JournalAmerican Journal of Public Health
Volume105
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Medicaid
Costs and Cost Analysis
Health
Quality-Adjusted Life Years
Insurance Benefits
Hypercholesterolemia
Joints
Hypertension

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Medicine(all)

Cite this

Considering whether Medicaid is worth the cost : Revisiting the Oregon Health Study. / Muennig, Peter A.; Quan, Ryan; Chiuzan, Codruta; Glied, Sharon.

In: American Journal of Public Health, Vol. 105, No. 5, 01.05.2015, p. 866-871.

Research output: Contribution to journalReview article

Muennig, Peter A. ; Quan, Ryan ; Chiuzan, Codruta ; Glied, Sharon. / Considering whether Medicaid is worth the cost : Revisiting the Oregon Health Study. In: American Journal of Public Health. 2015 ; Vol. 105, No. 5. pp. 866-871.
@article{cea324d5f4f34b59b016ca0adc477d6e,
title = "Considering whether Medicaid is worth the cost: Revisiting the Oregon Health Study",
abstract = "The Oregon Health Study was a groundbreaking experiment in which uninsured participants were randomized to either apply for Medicaid or stay with their current care. The study showed that Medicaid produced numerous important socioeconomic and health benefits but had no statistically significant impact on hypertension, hypercholesterolemia, or diabetes. Medicaid opponents interpreted the findings to mean that Medicaid is not a worthwhile investment. Medicaid proponents viewed the experiment as statistically underpowered and, irrespective of the laboratory values, suggestive that Medicaid is a good investment. We tested these competing claims and, using a sensitive joint test and statistical power analysis, confirmed that the Oregon Health Study did not improve laboratory values. However, we also found that Medicaid is a good value, with a cost of just $62 000 per quality-adjusted life-years gained.",
author = "Muennig, {Peter A.} and Ryan Quan and Codruta Chiuzan and Sharon Glied",
year = "2015",
month = "5",
day = "1",
doi = "10.2105/AJPH.2014.302485",
language = "English (US)",
volume = "105",
pages = "866--871",
journal = "American Journal of Public Health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
number = "5",

}

TY - JOUR

T1 - Considering whether Medicaid is worth the cost

T2 - Revisiting the Oregon Health Study

AU - Muennig, Peter A.

AU - Quan, Ryan

AU - Chiuzan, Codruta

AU - Glied, Sharon

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The Oregon Health Study was a groundbreaking experiment in which uninsured participants were randomized to either apply for Medicaid or stay with their current care. The study showed that Medicaid produced numerous important socioeconomic and health benefits but had no statistically significant impact on hypertension, hypercholesterolemia, or diabetes. Medicaid opponents interpreted the findings to mean that Medicaid is not a worthwhile investment. Medicaid proponents viewed the experiment as statistically underpowered and, irrespective of the laboratory values, suggestive that Medicaid is a good investment. We tested these competing claims and, using a sensitive joint test and statistical power analysis, confirmed that the Oregon Health Study did not improve laboratory values. However, we also found that Medicaid is a good value, with a cost of just $62 000 per quality-adjusted life-years gained.

AB - The Oregon Health Study was a groundbreaking experiment in which uninsured participants were randomized to either apply for Medicaid or stay with their current care. The study showed that Medicaid produced numerous important socioeconomic and health benefits but had no statistically significant impact on hypertension, hypercholesterolemia, or diabetes. Medicaid opponents interpreted the findings to mean that Medicaid is not a worthwhile investment. Medicaid proponents viewed the experiment as statistically underpowered and, irrespective of the laboratory values, suggestive that Medicaid is a good investment. We tested these competing claims and, using a sensitive joint test and statistical power analysis, confirmed that the Oregon Health Study did not improve laboratory values. However, we also found that Medicaid is a good value, with a cost of just $62 000 per quality-adjusted life-years gained.

UR - http://www.scopus.com/inward/record.url?scp=84926650549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926650549&partnerID=8YFLogxK

U2 - 10.2105/AJPH.2014.302485

DO - 10.2105/AJPH.2014.302485

M3 - Review article

VL - 105

SP - 866

EP - 871

JO - American Journal of Public Health

JF - American Journal of Public Health

SN - 0090-0036

IS - 5

ER -